Genedrive plc (GDR) Ordinary 0.015p Shares
0.19p
(22.82%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.19p
(22.82%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.19p
(22.82%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Share news, reports & tips
-
Genedrive signals potential £1m loan from shareholder David Nugent
31 October 2025 10:14
(Sharecast News) - AIM-listed Genedrive said on Friday that shareholder David Nugent had shown "willingness" to make a cash injection into the point-of-care pharmacogenetic testing company.
-
Genedrive's Saudi Arabian distribution partner inks MoU with Ministry of Health
28 October 2025 08:26
(Sharecast News) - Pharmacogenetic testing business Genedrive said on Tuesday that its exclusive distribution partner in the Kingdom of Saudi Arabia, iDeal iDea for Medical Equipment Technology, has signed a...
-
Genedrive flags doubling of full-year income
11 August 2025 15:50
(Sharecast News) - Genedrive said in an update on Monday that its full-year income for the 12 months ended June doubled to around £1m, from £0.5m a year earlier, driven by stronger second-half sales.
-
Genedrive secures CE certification for CYP2C19 ID Kit
30 May 2025 11:44
(Sharecast News) - Genedrive announced on Friday that it has secured CE certification for its CYP2C19 ID Kit under the European In Vitro Diagnostic Regulation (IVDR), allowing the pharmacogenetic test to be...
-
Genedrive upbeat on publication of clinical performance data
27 December 2024 12:27
(Sharecast News) - Point-of-care pharmacogenetic testing specialist Genedrive announced on Friday that clinical performance data for its Genedrive CYP2C19-ID Kit had been published in the Journal of...
-
Genedrive full-year revenue rises
29 November 2024 13:43
(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive reported a significant increase in revenue in its full-year results on Friday.
-
Director dealings: Genedrive chairman snaps up shares
15 August 2024 15:15
(Sharecast News) - Genedrive revealed on Thursday that chairman Ian Gilham had acquired 1.0m shares in the AIM-listed pharmacogenetic testing company.
-
Genedrive makes first commercial sales of CYP2C19-ID testing kit
12 August 2024 09:01
(Sharecast News) - Pharmacogenetic testing firm Genedrive said on Monday that it has made the first UK commercial sales of its CYP2C19-ID testing kit.
-
Genedrive test ordered by five Manchester area hospitals
24 May 2024 12:24
(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive announced on Friday that it has received initial orders for its Genedrive MT-RNR1 products from five additional UK hospitals in the...
-
Genedrive shares jump on NICE test recommendation
3 April 2024 13:54
(Sharecast News) - Genedrive shares were surging on Wednesday, after it received a significant endorsement from the UK's National Institute for Health and Care Excellence (NICE) regarding its...
-
Genedrive receives R&D tax credit, plans fundraise
15 March 2024 14:27
(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive announced the receipt of a research and development tax credit totalling £0.8m on Friday, taking its unaudited cash balances to...
-
Genedrive set to apply for NICE EVA funding
19 February 2024 10:56
(Sharecast News) - Genedrive shares rose on Monday, on the launch of the NICE early value assessment (EVA) evidence generation funding call, backed by the National Institute for Health and Care Research (NIHR).
Company announcements Announcements
-
Potential Shareholder Loan
31 October 2025 07:00
Genedrive
-
Holding(s) in Company
29 October 2025 16:35
Genedrive
-
MOU with Kingdom of Saudi Arabia for MT-RNR1 ID
28 October 2025 07:00
Genedrive
-
Application for Listing & Total Voting Rights
24 October 2025 16:30
Genedrive
-
Result of General Meeting
15 October 2025 10:49
Genedrive
-
Holding(s) in Company
10 October 2025 13:32
Genedrive
-
Holding(s) in Company
10 October 2025 13:31
Genedrive
-
Holding(s) in Company
10 October 2025 09:00
Genedrive
-
Further re Equity Financing
9 October 2025 10:23
Genedrive
-
Further re Equity Financing
6 October 2025 07:00
Genedrive
-
Holding(s) in Company
2 October 2025 18:18
Genedrive
-
Holding(s) in Company
1 October 2025 12:31
Genedrive
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.